NEWS

Pharmaceutical Industry news helps our clients to give competitive edge to their customers and also latest pharmaceutical industry news assists them in gaining updated knowledge. We bring you Global Pharmaceutical news about acquisitions, project undertakings, business and marketing, subjects, and industry related subjects, written in a professional, unbiased and thought-provoking format. Our international pharmaceutical News will help you enhance your business knowledge and productivity.

Eiger BioPharmaceuticals Inc said on Tuesday it would stop testing its drug ubenimex for the treatment of pulmonary arterial hypertension, a type of high blood pressure, after the drug failed to meet the main goal in a mid-stage study. The company said it would continue testing the drug for lymphedema,…

Celgene Corp is in talks to buy Juno Therapeutics Inc (JUNO.O), which is working on an experimental gene therapy drug to treat cancer, the Wall Street Journal reported on Tuesday, citing sources familiar with the matter. (on.wsj.com/2EMlysO) Shares of Juno, which has a market value of $5.57 billion, were up…

Hainan Poly Pharm Co Ltd Says it plans to set up a Hangzhou-based wholly owned medical technology unit, with registered capital of 2 million yuan. Says it plans to set up a Hainan-based wholly owned drug research institute unit, with registered capital of 2 million yuan.   Source: reuters.com

German drugmaker Dermapharm is preparing for an initial public offering (IPO), probably stealing a march on much larger Siemens’ healthcare unit Healthineers as the first stock market flotation in Germany this year. Dermapharm, which makes generic drugs, cosmetics, dietary products and medical devices, said on Monday it aimed to raise…

Hubei Jumpcan Pharmaceutical Co Ltd Says wholly owned pharmaceutical unit received goods manufacture practice (GMP) certificate from Shaanxi Food and Drug Administration. Certificate issued to unit’s products including troche, hard capsule and granula. Valid period is until Dec. 27, 2022.   Source: reuters.com

CannaRoyalty Corp. and Aequus Pharmaceuticals Inc., announced a collaboration (the "JV") to advance a suite of cannabis-based therapies targeting neurological disorders into clinical trials in Canada, in collaboration with Canadian doctors and key opinion leaders. CannaRoyalty and Aequus have formed this collaboration to clinically advance a number of cannabis-based therapies…

Syapse, a leading precision medicine company, announced today it has entered into a multi-year strategic collaboration with Roche to make precision medicine a reality for more cancer patients and their healthcare providers. Syapse and Roche will work jointly to develop software products and analytics solutions that empower healthcare providers with…

Denmark’s Novo Nordisk, the world’s biggest insulin maker, went public with a 2.6 billion euro ($3.1 billion) bid for Belgian biotech group Ablynx on Monday, seeking a new source of growth by bolstering its treatments for rare blood disorders. Ablynx rejected Novo’s latest takeover approach and analysts predict the Danish…

France’s Sanofi and U.S Regeneron said on Monday they would inject an additional $1 billion in the development of cemiplimab, an antibody that could, if successful, be used to treat a wide range of cancers. In a statement, the two companies said they would also accelerate the co-development of dupilumab,…

Pfizer Inc (PFE.N) is abandoning research to find new drugs aimed at treating Alzheimer’s and Parkinson’s disease, the U.S. pharmaceutical company announced on Saturday. The company said it expects to eliminate 300 positions from the neuroscience discovery and early development programs in Andover and Cambridge, Massachusetts, and Groton, Connecticut, as…

loadmore..